Literature DB >> 27401150

Deferring allogeneic transplantation for adult acute lymphoblastic leukemia: is there a second chance?

Veronika Bachanova1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27401150      PMCID： PMC5565397          DOI： 10.1080/10428194.2016.1205745

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  13 in total

1.  Treatment of high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual disease after consolidation assessed by flow cytometry: final results of the PETHEMA ALL-AR-03 trial.

Authors:  Josep-Maria Ribera; Albert Oriol; Mireia Morgades; Pau Montesinos; Josep Sarrà; José González-Campos; Salut Brunet; Mar Tormo; Pascual Fernández-Abellán; Ramon Guàrdia; María-Teresa Bernal; Jordi Esteve; Pere Barba; María-José Moreno; Arancha Bermúdez; Antonia Cladera; Lourdes Escoda; Raimundo García-Boyero; Eloy Del Potro; Juan Bergua; María-Luz Amigo; Carlos Grande; María-José Rabuñal; Jesús-María Hernández-Rivas; Evarist Feliu
Journal:  J Clin Oncol       Date:  2014-04-21       Impact factor: 44.544

2.  The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission.

Authors:  David I Marks; Tao Wang; Waleska S Pérez; Joseph H Antin; Edward Copelan; Robert Peter Gale; Biju George; Vikas Gupta; Joerg Halter; H Jean Khoury; Thomas R Klumpp; Hillard M Lazarus; Victor A Lewis; Philip McCarthy; David A Rizzieri; Mitchell Sabloff; Jeff Szer; Martin S Tallman; Daniel J Weisdorf
Journal:  Blood       Date:  2010-04-19       Impact factor: 22.113

3.  Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study.

Authors:  Françoise Huguet; Thibaut Leguay; Emmanuel Raffoux; Xavier Thomas; Kheira Beldjord; Eric Delabesse; Patrice Chevallier; Agnes Buzyn; André Delannoy; Yves Chalandon; Jean-Paul Vernant; Marina Lafage-Pochitaloff; Agnès Chassevent; Véronique Lhéritier; Elizabeth Macintyre; Marie-Christine Béné; Norbert Ifrah; Hervé Dombret
Journal:  J Clin Oncol       Date:  2009-01-05       Impact factor: 44.544

4.  Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial.

Authors:  E Tavernier; J-M Boiron; F Huguet; K Bradstock; N Vey; T Kovacsovics; A Delannoy; N Fegueux; P Fenaux; A Stamatoullas; O Tournilhac; A Buzyn; O Reman; C Charrin; C Boucheix; J Gabert; V Lhéritier; J-P Vernant; H Dombret; X Thomas
Journal:  Leukemia       Date:  2007-07-05       Impact factor: 11.528

5.  Pediatric-inspired therapy compared to allografting for Philadelphia chromosome-negative adult ALL in first complete remission.

Authors:  Matthew D Seftel; Donna Neuberg; Mei-Jie Zhang; Hai-Lin Wang; Karen Kuhn Ballen; Julie Bergeron; Stephen Couban; César O Freytes; Mehdi Hamadani; Mohamed A Kharfan-Dabaja; Hillard M Lazarus; Taiga Nishihori; Kristjan Paulson; Wael Saber; Stephen E Sallan; Robert Soiffer; Martin S Tallman; Ann E Woolfrey; Daniel J DeAngelo; Daniel J Weisdorf
Journal:  Am J Hematol       Date:  2016-03       Impact factor: 10.047

6.  In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993).

Authors:  Anthony H Goldstone; Susan M Richards; Hillard M Lazarus; Martin S Tallman; Georgina Buck; Adele K Fielding; Alan K Burnett; Raj Chopra; Peter H Wiernik; Letizia Foroni; Elisabeth Paietta; Mark R Litzow; David I Marks; Jill Durrant; Andrew McMillan; Ian M Franklin; Selina Luger; Niculae Ciobanu; Jacob M Rowe
Journal:  Blood       Date:  2007-11-29       Impact factor: 22.113

7.  Evaluation of allogeneic transplantation in first or later minimal residual disease - negative remission following adult-inspired therapy for acute lymphoblastic leukemia.

Authors:  Ryan D Cassaday; D Alan Potts; Philip A Stevenson; Merav Bar; George E Georges; Andrei R Shustov; Mohamed L Sorror; Brent L Wood; Colleen Delaney; Kristine C Doney; Rainer F Storb; Brenda M Sandmaier
Journal:  Leuk Lymphoma       Date:  2016-03-22

8.  Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study.

Authors:  Adele K Fielding; Susan M Richards; Rajesh Chopra; Hillard M Lazarus; Mark R Litzow; Georgina Buck; I Jill Durrant; Selina M Luger; David I Marks; Ian M Franklin; Andrew K McMillan; Martin S Tallman; Jacob M Rowe; Anthony H Goldstone
Journal:  Blood       Date:  2006-10-10       Impact factor: 22.113

9.  Long-term outcome of a pediatric-inspired regimen used for adults aged 18-50 years with newly diagnosed acute lymphoblastic leukemia.

Authors:  D J DeAngelo; K E Stevenson; S E Dahlberg; L B Silverman; S Couban; J G Supko; P C Amrein; K K Ballen; M D Seftel; A R Turner; B Leber; K Howson-Jan; K Kelly; S Cohen; J H Matthews; L Savoie; M Wadleigh; L A Sirulnik; I Galinsky; D S Neuberg; S E Sallan; R M Stone
Journal:  Leukemia       Date:  2014-07-31       Impact factor: 11.528

10.  Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease.

Authors:  V Bachanova; D I Marks; M-J Zhang; H Wang; M de Lima; M D Aljurf; M Arellano; A S Artz; U Bacher; J-Y Cahn; Y-B Chen; E A Copelan; W R Drobyski; R P Gale; J P Greer; V Gupta; G A Hale; P Kebriaei; H M Lazarus; I D Lewis; V A Lewis; J L Liesveld; M R Litzow; A W Loren; A M Miller; M Norkin; B Oran; J Pidala; J M Rowe; B N Savani; W Saber; R Vij; E K Waller; P H Wiernik; D J Weisdorf
Journal:  Leukemia       Date:  2013-08-30       Impact factor: 11.528
View more
  1 in total

1.  Allogeneic transplantation for Ph+ acute lymphoblastic leukemia with posttransplantation cyclophosphamide.

Authors:  Jonathan A Webster; Leo Luznik; Hua-Ling Tsai; Philip H Imus; Amy E DeZern; Keith W Pratz; Mark J Levis; Ivana Gojo; Margaret M Showel; Gabrielle Prince; Javier Bolaños-Meade; Lukasz P Gondek; Gabriel Ghiaur; W Brian Dalton; Tania Jain; Ephraim J Fuchs; Douglas E Gladstone; Christian B Gocke; Syed Abbas Ali; Carol Ann Huff; Ivan M Borrello; Lode Swinnen; Nina Wagner-Johnston; Richard F Ambinder; Richard J Jones; B Douglas Smith
Journal:  Blood Adv       Date:  2020-10-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.